Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High EGFR gene copy number predicts poor outcome in triple-negative breast cancer.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Sept 2014

Park Heae Surng, Jang Min Hye, Kim Eun Joo, Kim Hyun Jeong, Lee Hee Jin, Kim Yu Jung, Kim Jee Hyun, Kang Eunyoung, Kim Sung-Won, Kim In Ah, Park So Yeon

Abstract excerpt

Epidermal growth factor receptor (EGFR) is frequently overexpressed in triple-negative breast cancer and is emerging as a therapeutic target. EGFR gene copy number alteration and mutation are highly variable and scientists have been challenged to define their prognostic significance in triple-negative breast cancer. We examined EGFR protein expression, EGFR gene copy number alteration and mutation of exon 18 to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Medullary
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Dosage

Share to Genes, erbB-1

Share to In Situ Hybridization, Fluorescence

Share to Ki-67 Antigen

Share to Tissue Array Analysis

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 24406864
DOI: 10.1038/modpathol.2013.251

Genes

EGFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High EGFR gene copy number predicts poor outcome in triple-negative breast cancer.PMID 24406864Read ↗

Epidermal growth factor receptor (EGFR) gene alteration and protein overexpression in Malaysian triple-negative breast cancer (TNBC) cohortSemantic proximity Read ↗

Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.Semantic proximity Read ↗

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast CancerSemantic proximity Read ↗

Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.Semantic proximity Read ↗

Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy.Semantic proximity Read ↗

ALK protein expression and gene copy number alterations in triple-negative breast cancer: Clinical implications.Semantic proximity Read ↗

New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile.Semantic proximity Read ↗

EGFR expression and gene copy number in triple-negative breast carcinomaSemantic proximity Read ↗

Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.Semantic proximity Read ↗

DNA copy number alterations and expression of relevant genes in triple‐negative breast cancerSemantic proximity Read ↗

Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancerSemantic proximity Read ↗

Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.